Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
483.80
+2.80 (0.58%)
Jul 31, 2026, 4:08 PM HKT
HKG:6990 Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, HKG:6990 stock has a consensus rating of "Strong Buy" and an average price target of $567.11. The average 1-year stock price forecast is 17.22% higher than the current stock price, while the lowest is $500.70 (+3.49%) and the highest is $666.57 (+37.78%).
Price Target: $567.11 (+17.22%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:6990 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 16 | 16 | 15 | 15 | 15 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 19 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Nomura No rating | Nomura | Buy Maintains $544.42 → $612.66 | Buy | Maintains | $544.42 → $612.66 | +26.63% | Jul 24, 2026 |
Unknown Analyst SPDB No rating | SPDB | Buy Maintains $611.60 | Buy | Maintains | $611.60 | +26.42% | Jul 21, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $648.00 | Buy | Maintains | $648.00 | +33.94% | Jul 16, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $625.00 → $667.00 | Buy | Maintains | $625.00 → $667.00 | +37.87% | Jul 15, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $550.00 | Buy | Maintains | $550.00 | +13.68% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
2.72B
from 2.06B
Increased by 32.03%
Revenue Next Year
4.62B
from 2.72B
Increased by 69.88%
EPS This Year
-0.34
from -1.04
EPS Next Year
3.37
from -0.34
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.